TABLE 1.

aPR by age, sex and altitude of residence to consider the cluster effect of data on certain locations

Pre‐existing condition	n	SARS‐CoV‐2 infection	COVID‐19 pneumonia	Admission	ICU admission	Fatalities
	Prevalence	aPr/95% CI	aPr/95% CI	aPr/95% CI	aPr/95% CI	aPr/95% CI
Immunodeficiencies	808	0.773	3.919	8.774	0.913	14.436
	3.80%	0.664 to 0.882	1.14 to 6.69	6.01 to 11.49	−0.3 to 2.13	−0.99 to 29.86
Asthma	806	0.904	1.048	0.642	1.998	—
	3.80%	0.793 to 1.015	−0.16 to 2.11	0.02 to 1.27	−1.7 to 5.7	—
Obesity	655	1.390	4.504	2.467	0.802	2.644
	3.10%	1.25 to 1.53	2.17 to 6.84	1.46 to 3.46	−0.37 to 1.98	−0.7 to 5.9
CV diseases	357	0.892	3.969	4.131	—	0.000
	1.70%	0.707 to 1.08	−1.48 to 9.42	0.72 to 7.54	—	−0.000011 to 0.00000226
CKD	167	0.800	4.528	5.860	3.842	6.424
	0.80%	0.571 to 1.03	0.12 to 8.93	2.4 to 9.3	−0.16 to 7.84	−7.1 to 19.9
HTA	152	1.108	3.948	7.746	—	0.000
	0.70%	0.827 to 1.389	−0.47 to 8.4	4.12 to 11.36	—	−0.0000106 to 0.0000223
DBM	132	1.209	5.265	3.954	0.000	0.000
	0.60%	0.894 to 1.524	−0.49 to 11.02	0.25 to 7.65	−1.13e‐06 to 6.18e‐06	−0.0000101 to 0.0000204

Note: aPR presented along 95% confidence intervals. Bold: Statistically significant results, P < .05.

Abbreviations: aPR, adjusted prevalence ratio; CKD, chronic kidney disease; CV, cardiovascular; DBM, diabetes; HTA, hypertension.